T1	CHEM 18 29	haloperidol
#1	AnnotatorNotes T1	C0018546; haloperidol; Organic Chemical · Pharmacologic Substance
T2	CHEM 31 43	dexametasona
#2	AnnotatorNotes T2	C0011777; dexamethasone; Organic Chemical · Pharmacologic Substance
T3	CHEM 46 57	ondansetrón
#3	AnnotatorNotes T3	C0061851; ondansetron; Organic Chemical · Pharmacologic Substance
T4	DISO 233 237	NVPO
#4	AnnotatorNotes T4	C0520909; Postoperative Nausea and Vomiting; Sign or Symptom
T5	DISO 82 88	náusea
#5	AnnotatorNotes T5	C0027497; Nausea; Sign or Symptom
T6	CHEM 109 116	morfina
#6	AnnotatorNotes T6	C0026549; morphine; Organic Chemical · Pharmacologic Substance
T7	DISO 380 399	eventos no deseados
#7	AnnotatorNotes T7	C0877248; Adverse event; Pathologic Function (?)
T8	PROC 131 166	gastrectomía vertical laparoscópica
#8	AnnotatorNotes T8	C3161277; Laparoscopic vertical (sleeve) gastrectomy; Therapeutic or Preventive Procedure (?)
T9	DISO 198 204	náusea
#9	AnnotatorNotes T9	C0027497; Nausea; Sign or Symptom
T10	PROC 1057 1079	escala numérica verbal
#10	AnnotatorNotes T10	C4275132; Assessment using Verbal Rating Scale; Diagnostic Procedure
T11	PROC 592 627	gastrectomía vertical laparoscópica
#11	AnnotatorNotes T11	C3161277; Laparoscopic vertical (sleeve) gastrectomy; Therapeutic or Preventive Procedure (?)
T12	PROC 270 302	cirugía bariátrica laparoscópica
#12	AnnotatorNotes T12	C1610674; Laparoscopic Bariatric Surgery Procedures; Therapeutic or Preventive Procedure
T13	PROC 629 632	GVL
#13	AnnotatorNotes T13	C3161277; Laparoscopic vertical (sleeve) gastrectomy; Therapeutic or Preventive Procedure (?)
T14	CHEM 321 332	haloperidol
#14	AnnotatorNotes T14	C0018546; haloperidol; Organic Chemical · Pharmacologic Substance
T15	CHEM 334 346	dexametasona
#15	AnnotatorNotes T15	C0011777; dexamethasone; Organic Chemical · Pharmacologic Substance
T16	CHEM 349 360	ondansetrón
#16	AnnotatorNotes T16	C0061851; ondansetron; Organic Chemical · Pharmacologic Substance
T17	PROC 730 753	índice de masa corporal
#17	AnnotatorNotes T17	C0005893; Body mass index procedure; Diagnostic Procedure | C3698309; Measurement of body mass index; Health Care Activity
T18	DISO 210 231	vómito postoperatorio
#18	AnnotatorNotes T18	C0520905; Vomiting, Postoperative; Sign or Symptom
T19	DISO 458 464	náusea
#19	AnnotatorNotes T19	C0027497; Nausea; Sign or Symptom
T20	DISO 500 506	vómito
#20	AnnotatorNotes T20	C0042963; Vomiting; Sign or Symptom
T21	CHEM 523 530	morfina
#21	AnnotatorNotes T21	C0026549; morphine; Organic Chemical · Pharmacologic Substance
T22	DISO 570 576	obesos
#22	AnnotatorNotes T22	C0028754; Obesity; Disease or Syndrome
T23	PROC 1762 1765	GVL
#23	AnnotatorNotes T23	C3161277; Laparoscopic vertical (sleeve) gastrectomy; Therapeutic or Preventive Procedure (?)
T24	PROC 644 699	Estudio clínico, aleatorizado, controlado y doble ciego
#24	AnnotatorNotes T24	C0013072; Double-Blind Method; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T25	CHEM 846 857	ondansetrón
#25	AnnotatorNotes T25	C0061851; ondansetron; Organic Chemical · Pharmacologic Substance
T26	CHEM 880 891	ondansetrón
#26	AnnotatorNotes T26	C0061851; ondansetron; Organic Chemical · Pharmacologic Substance
T27	CHEM 899 911	dexametasona
#27	AnnotatorNotes T27	C0011777; dexamethasone; Organic Chemical · Pharmacologic Substance
T28	CHEM 936 947	ondansetrón
#28	AnnotatorNotes T28	C0061851; ondansetron; Organic Chemical · Pharmacologic Substance
T29	CHEM 954 966	dexametasona
#29	AnnotatorNotes T29	C0011777; dexamethasone; Organic Chemical · Pharmacologic Substance
T30	CHEM 974 985	haloperidol
#30	AnnotatorNotes T30	C0018546; haloperidol; Organic Chemical · Pharmacologic Substance
T31	DISO 1026 1032	náusea
#31	AnnotatorNotes T31	C0027497; Nausea; Sign or Symptom
T32	DISO 1119 1125	vómito
#32	AnnotatorNotes T32	C0042963; Vomiting; Sign or Symptom
T33	CHEM 1142 1149	morfina
#33	AnnotatorNotes T33	C0026549; morphine; Organic Chemical · Pharmacologic Substance
T34	DISO 1235 1241	náusea
#34	AnnotatorNotes T34	C0027497; Nausea; Sign or Symptom
T35	CHEM 1409 1416	morfina
#35	AnnotatorNotes T35	C0026549; morphine; Organic Chemical · Pharmacologic Substance
T36	DISO 1522 1528	vómito
#36	AnnotatorNotes T36	C0042963; Vomiting; Sign or Symptom
T37	CHEM 1591 1602	haloperidol
#37	AnnotatorNotes T37	C0018546; haloperidol; Organic Chemical · Pharmacologic Substance
T38	CHEM 1604 1616	dexametasona
#38	AnnotatorNotes T38	C0011777; dexamethasone; Organic Chemical · Pharmacologic Substance
T39	CHEM 1619 1630	ondansetrón
#39	AnnotatorNotes T39	C0061851; ondansetron; Organic Chemical · Pharmacologic Substance
T40	DISO 1675 1681	náusea
#40	AnnotatorNotes T40	C0027497; Nausea; Sign or Symptom
T41	CHEM 1710 1717	morfina
#41	AnnotatorNotes T41	C0026549; morphine; Organic Chemical · Pharmacologic Substance
T42	DISO 1740 1746	obesos
#42	AnnotatorNotes T42	C0028754; Obesity; Disease or Syndrome
T43	DISO 90 95	dolor
#43	AnnotatorNotes T43	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T44	DISO 467 472	dolor
#44	AnnotatorNotes T44	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T45	ANAT 745 753	corporal
#45	AnnotatorNotes T45	C0460148; Human body structure; Anatomical Structure | C1318419; Entire human body; Anatomical Structure
T46	DISO 1035 1040	dolor
#46	AnnotatorNotes T46	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T47	DISO 1324 1329	dolor
#47	AnnotatorNotes T47	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T48	DISO 1687 1692	dolor
#48	AnnotatorNotes T48	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T50	Time 217 231	postoperatorio
#49	AnnotatorNotes T50	C0032790; Postoperative Period; Temporal Concept
T55	Time 537 551	postoperatorio
#50	AnnotatorNotes T55	C0032790; Postoperative Period; Temporal Concept
T56	Time 553 555	PO
#51	AnnotatorNotes T56	C0032790; Postoperative Period; Temporal Concept
T57	LIVB 560 569	pacientes
#52	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T58	LIVB 716 725	pacientes
#53	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T60	LIVB 770 779	pacientes
#54	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T61	Dose 858 862	8 mg
T62	Dose 892 896	8 mg
T63	Dose 912 916	8 mg
T64	Dose 948 952	8 mg
T65	Dose 967 971	8 mg
T66	Dose 986 990	2 mg
T68	Duration 1167 1197	0-2, 2-12, 12-24 y 24-36 horas
T69	Time 1201 1203	PO
#55	AnnotatorNotes T69	C0032790; Postoperative Period; Temporal Concept
T73	Time 1724 1726	PO
#56	AnnotatorNotes T73	C0032790; Postoperative Period; Temporal Concept
T74	LIVB 1730 1739	pacientes
#57	AnnotatorNotes T74	C0030705; Patients; Patient or Disabled Group
R1	Combined_with Arg1:T1 Arg2:T2	
R2	Combined_with Arg1:T2 Arg2:T3	
R4	After Arg1:T43 Arg2:T8	
R5	After Arg1:T5 Arg2:T8	
R6	Used_for Arg1:T1 Arg2:T8	
R7	After Arg1:T6 Arg2:T8	
R3	Overlap Arg1:T18 Arg2:T50	
R8	Overlap Arg1:T4 Arg2:T50	
R9	Overlap Arg1:T9 Arg2:T50	
R10	After Arg1:T9 Arg2:T12	
R11	After Arg1:T18 Arg2:T12	
R12	After Arg1:T4 Arg2:T12	
R13	Combined_with Arg1:T14 Arg2:T15	
R14	Combined_with Arg1:T15 Arg2:T16	
R15	Before Arg1:T14 Arg2:T7	
R16	Overlap Arg1:T19 Arg2:T55	
R17	Overlap Arg1:T44 Arg2:T55	
R18	Overlap Arg1:T20 Arg2:T55	
R19	Overlap Arg1:T19 Arg2:T56	
R20	Overlap Arg1:T44 Arg2:T56	
R21	Overlap Arg1:T20 Arg2:T56	
R22	Overlap Arg1:T21 Arg2:T55	
R23	Overlap Arg1:T21 Arg2:T56	
R24	Experiences Arg1:T57 Arg2:T22	
R25	Experiences Arg1:T57 Arg2:T11	
R26	Experiences Arg1:T57 Arg2:T13	
R27	Experiences Arg1:T57 Arg2:T21	
R28	Experiences Arg1:T57 Arg2:T20	
R29	Experiences Arg1:T57 Arg2:T44	
R30	Experiences Arg1:T57 Arg2:T19	
R31	Before Arg1:T11 Arg2:T19	
R32	Before Arg1:T11 Arg2:T44	
R33	Before Arg1:T11 Arg2:T20	
R34	Before Arg1:T11 Arg2:T21	
R35	Before Arg1:T13 Arg2:T19	
R36	Before Arg1:T13 Arg2:T44	
R37	Before Arg1:T13 Arg2:T20	
R38	Before Arg1:T13 Arg2:T21	
R39	Experiences Arg1:T58 Arg2:T17	
R40	Location_of Arg1:T45 Arg2:T17	
T49	Result_or_Value 754 764	> 35 Kg/m2
R41	Has_Result_or_Value Arg1:T17 Arg2:T49	
R42	Experiences Arg1:T60 Arg2:T25	
R43	Has_Dose_or_Strength Arg1:T25 Arg2:T61	
R44	Combined_with Arg1:T26 Arg2:T27	
R45	Has_Dose_or_Strength Arg1:T26 Arg2:T62	
R46	Has_Dose_or_Strength Arg1:T27 Arg2:T63	
R47	Experiences Arg1:T60 Arg2:T26	
R48	Experiences Arg1:T60 Arg2:T28	
R49	Has_Dose_or_Strength Arg1:T28 Arg2:T64	
R50	Has_Dose_or_Strength Arg1:T29 Arg2:T65	
R51	Has_Dose_or_Strength Arg1:T30 Arg2:T66	
R52	Combined_with Arg1:T28 Arg2:T29	
R53	Combined_with Arg1:T29 Arg2:T30	
R54	Overlap Arg1:T46 Arg2:T69	
R55	Overlap Arg1:T31 Arg2:T69	
R56	Overlap Arg1:T32 Arg2:T69	
R57	Overlap Arg1:T33 Arg2:T69	
R58	Overlap Arg1:T46 Arg2:T68	
R59	Overlap Arg1:T31 Arg2:T68	
R60	Overlap Arg1:T32 Arg2:T68	
R61	Overlap Arg1:T10 Arg2:T69	
R62	Overlap Arg1:T10 Arg2:T68	
T51	Neg_cue 1474 1476	No
T52	CONC 1482 1492	diferencia
A1	Assertion T52 Negated
#58	AnnotatorNotes T52	C1705241; Delta (difference); Quantitative Concept
R63	Negation Arg1:T51 Arg2:T52	
R65	Overlap Arg1:T46 Arg2:T33	
R66	Overlap Arg1:T44 Arg2:T21	
R68	Combined_with Arg1:T37 Arg2:T38	
R69	Combined_with Arg1:T38 Arg2:T39	
R71	Overlap Arg1:T48 Arg2:T73	
R72	Overlap Arg1:T41 Arg2:T73	
R73	Overlap Arg1:T40 Arg2:T73	
R74	Before Arg1:T1 Arg2:T5	
R75	Before Arg1:T1 Arg2:T43	
R76	Before Arg1:T1 Arg2:T6	
R77	Before Arg1:T37 Arg2:T40	
R78	Before Arg1:T37 Arg2:T48	
R79	Before Arg1:T37 Arg2:T41	
R80	Experiences Arg1:T74 Arg2:T42	
R81	Experiences Arg1:T74 Arg2:T23	
R82	Experiences Arg1:T74 Arg2:T37	
R83	Experiences Arg1:T74 Arg2:T40	
R84	Experiences Arg1:T74 Arg2:T48	
R85	Experiences Arg1:T74 Arg2:T41	
R86	Used_for Arg1:T37 Arg2:T23	
R87	Before Arg1:T23 Arg2:T40	
R88	Before Arg1:T23 Arg2:T48	
R89	Before Arg1:T23 Arg2:T41	
A2	Experiencer T57 Patient
A3	Experiencer T58 Patient
A4	Experiencer T60 Patient
A5	Experiencer T74 Patient
